CTVA
Get informed when a big investor buys or sells
+ FollowJuly 31, 2026 - AI Summary
Undervalued by 66.9% based on the discounted cash flow analysis.
| Market cap | $56.12 Billion |
|---|---|
| Enterprise Value | $59.31 Billion |
| Dividend Yield | $0.72 (0.86%) |
| Earnings per Share | $1.6 |
| Beta | 0.58 |
| Outstanding Shares | 670,400,000 |
| P/E Ratio | 55.57 |
|---|---|
| PEG | -477.22 |
| Price to Sales | 3.23 |
| Price to Book Ratio | 2.27 |
| Enterprise Value to Revenue | 3.33 |
| Enterprise Value to EBIT | 32.38 |
| Enterprise Value to Net Income | 58 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.22 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.6726▲ 43.11% |
|---|---|
| Total Calls | 511,600▼ 50.03% |
| Total Puts | 344,100▲ 39.17% |
Holdings and activity of institutional investors.
| Ownership % | 109.90%▲ 23.69% |
|---|---|
| Total Invested | $52.14B▲ 7.70% |
| Investors Holding | 1,516▲ 8.00% |
No data
Corteva Agriscience is a publicly traded, global pure-play agriculture company that provides farmers around the world with the most complete portfolio in the industry - including a balanced and diverse mix of seed, crop protection and di...